Loading this company
Loading this company
Priced within our range of A$49.06 to A$135.28.
A$132.55AUD up +A$1.42 (+1.08%)
Quoted · Prices are delayed.
Showing the last price we hold for this listing, recorded 2026-10-19 14:40 UTC (6 hours ago).
Nothing we can cite explains today’s move for this company.
Our range from 4 models, on today’s numbers
A$49.06–A$135.28
What the price needs: revenue growth of 10.3%/yr for 5 years (our model assumes 2.4%).
Led by discounted cash flow (DCF) · Steady cash-flow business
Price A$132.55Priced · Prices are delayed.
Our forward range over 12 months is part of Pro. See plans
Analysts’ mean target
A$136.15 across 16 analysts
The high and low of the analyst range is part of Pro. See plans
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. It operates in the Medical Devices industry (Healthcare sector), headquartered in Australia. The company employs roughly 5,400 people.
Prices are delayed. The feed does not say when these figures were taken.
No filings or corporate activity on file in the recent window.
No recent headlines we can cite for this company.
No insider filings for this company in the recent window.
Not investment advice. TickerWorth Score is a model output.
The score, the fair value and the reverse DCF are free on every company. Pro lets you change growth, margin and the discount rate yourself, see every valuation lens and its working, and download the model. Start a 7-day free trial — a card is required and you can cancel any time before it ends. $99 a year, or $14.99 monthly.